Taurine is widely recognized as an ingredient in energy drinks, but its effects on the brain differ from those of stimulants. This amino acid can activate receptors associated with calming neural activity and may influence systems involved in psychosis, depression, anxiety and ADHD-like behavior.
Taurine is among the most abundant amino acids in the brain. Rather than serving as a building block for proteins, it helps regulate cellular salt and water balance, protects against oxidative stress and supports mitochondria. It can activate GABA-A and glycine receptors, which reduce the firing of nerve cells, and it also blocks NMDA receptors, the same type of glutamate receptor affected by ketamine.
The strongest evidence in humans comes from a double-blind, placebo-controlled Australian trial involving young people aged 18 to 25 who were experiencing their first episode of psychosis. The 86 participants were taking low-dose antipsychotic medication and received either 4 grams of taurine or a placebo daily for 12 weeks. Those who received taurine experienced greater reductions in overall psychiatric and psychotic symptoms, while depressive symptoms and daily functioning also improved. The supplement was well tolerated.
Researchers have also observed that people with an untreated first episode of psychosis can have elevated blood taurine levels, which return to normal after antipsychotic treatment. This could reflect an attempt by the body to moderate excessive brain activity, although the finding does not establish taurine as a treatment on its own.
Evidence for depression remains less conclusive. In animal studies, taurine prevented stress-related loss of interest, protected memory and supported the growth of new neurons in the hippocampus. However, human findings are more complicated: people with untreated major depression have sometimes shown higher blood taurine levels, and a systematic review found inconsistent effects on mood.
Studies of anxiety have also produced mixed results. A single dose reduced anxiety-like behavior in mice without impairing memory or muscle function, possibly through glycine receptors. In contrast, mice that consumed taurine in drinking water over a longer period showed increased anxiety. The difference may be related to dose, duration or the way taurine was administered.
Research into ADHD is still limited to animal models. In spontaneously hypertensive rats, dietary taurine reduced inflammatory markers, altered brain activity and improved working memory. High and low doses affected dopamine processing differently, suggesting that the amount consumed may be important. No human ADHD trials have been published.
Taurine has generally shown a favorable safety profile. A review of human studies identified 3 grams per day as a safe amount for healthy adults, while higher doses, including the 4 grams used in the psychosis trial, have been studied without serious problems. Possible side effects include stomach upset. Taurine is also recognized by the U.S. Food and Drug Administration as generally recognized as safe as a food ingredient.
Energy drinks are not an ideal source because their caffeine and sugar content can worsen anxiety and interfere with sleep. Anyone considering taurine, particularly people taking psychiatric medication, should discuss it with a doctor. Current evidence most strongly supports taurine as a possible add-on treatment in early psychosis; its potential role in depression, anxiety and ADHD remains largely investigational.
Sources: Psychology Today.